omeprazole has been researched along with prednisone in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (15.79) | 18.2507 |
2000's | 20 (52.63) | 29.6817 |
2010's | 11 (28.95) | 24.3611 |
2020's | 1 (2.63) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chosidow, O; Espagne, E; Joly, P; Laurent-Puig, P; Prost, C; Revuz, J; Roujeau, JC; Wechsler, J | 1 |
Chosidow, O; Delchier, JC; Joly, P; Laurent-Poig, P; Revuz, J; Roujeau, JC | 1 |
Meiser, BM; Muschiol, F; Nollert, G; Pfeiffer, M; Reichart, B; Reichenspurner, H; Uberfuhr, P; Vetter, HO; Wagner, F | 1 |
Criss, DG; Geissinger, BW; Sharkey, MF; Wu, WC | 1 |
Cavanaugh, JH; Karol, MD | 1 |
Borum, ML; Marks, ZH | 1 |
Abraham, D; Saltoun, CA | 1 |
Füessl, HS | 1 |
Ra, A; Tobe, SW | 1 |
Cury, EK; Faintuch, S; Schraibman, V | 1 |
Calvo, C; García, H; Hernández-Jaras, J; Maduell, F; Rovira, RE; Torregrosa, E | 1 |
Hinner, H; Kraus, J; Schuppert, F; Tiesmeier, J | 1 |
Bartsch, R; Drach, J; Hejna, M; Raderer, M; Wöhrer, S | 1 |
Cohen, S; Givony, S; Granot, E; Kori, M; Levine, A; Melzer, E; Sokolovskaia-Ziv, N | 1 |
Antonio Gil Ruiz, J; Barrio, J; Caro-Patón, A; Gil-Simón, P; Julián, L; Pérez-Miranda, M; Saracíbar, E | 1 |
Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
de Barros e Silva, MJ; de Paiva, TF; Fanelli, MF; Gimenes, DL; Rinck, JA | 1 |
Li, X; Liang, S; Liu, B; Lü, H; Qiu, Z; Wang, L; Wang, Y; Wei, W; Yu, L | 1 |
Alvarez López, A; Nadal Reus, J; Piñero Rodríguez, AM | 1 |
Jean-Louis, MF; Sanders, JG | 1 |
Flores, RM; Kanth, R; Shah, MS | 1 |
Althaf, MM; Nadri, Q | 1 |
Bilancio, G; Cirillo, C; Cirillo, M | 1 |
Asif, A; Haqqie, S; Pokharel, S; Tobin, E | 1 |
Moyers, TD; Price, JM; Rak, MB; Whittemore, JC | 1 |
4 review(s) available for omeprazole and prednisone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Reversible esophageal motility disorder in a patient with sarcoidosis.
Topics: Adult; Deglutition Disorders; Drug Therapy, Combination; Esophageal Motility Disorders; Esophagus; Female; Glucocorticoids; Humans; Manometry; Omeprazole; Prednisone; Sarcoidosis | 1996 |
Esophageal stricture from idiopathic ulcers in an AIDS patient: a case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Ulcer Agents; Biopsy; Endoscopy, Digestive System; Esophageal Diseases; Esophageal Stenosis; Esophagus; Follow-Up Studies; Glucocorticoids; Humans; Male; Omeprazole; Prednisone; Ulcer | 1999 |
[Acute interstitial nephritis associated with omeprazole therapy].
Topics: Acute Disease; Aged; Combined Modality Therapy; Enzyme Inhibitors; Female; Gastroesophageal Reflux; Humans; Middle Aged; Myocardial Ischemia; Nephritis, Interstitial; Omeprazole; Prednisone; Renal Dialysis | 2004 |
4 trial(s) available for omeprazole and prednisone
Article | Year |
---|---|
Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Anti-Ulcer Agents; Antilymphocyte Serum; Azathioprine; Cimetidine; Cyclosporine; Drug Combinations; Famotidine; Female; Heart Transplantation; Humans; Intestinal Absorption; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pirenzepine; Prednisone; Rats; Rats, Inbred BN | 1994 |
Lack of pharmacokinetic interaction after administration of lansoprazole or omeprazole with prednisone.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Glucocorticoids; Humans; Lansoprazole; Male; Omeprazole; Placebos; Prednisone; Proton Pump Inhibitors | 1996 |
Efficacy and safety of modified sequential three-step empirical therapy for chronic cough.
Topics: Adult; Aminophylline; Antitussive Agents; Budesonide; Cetirizine; Chlorpheniramine; Chronic Disease; Cough; Domperidone; Drug Therapy, Combination; Empirical Research; Humans; Methamphetamine; Middle Aged; Noscapine; Omeprazole; Prednisone; Prospective Studies; Quality of Life; Sleep Stages; Treatment Outcome | 2010 |
Clinicopathologic and gastrointestinal effects of administration of prednisone, prednisone with omeprazole, or prednisone with probiotics to dogs: A double-blind randomized trial.
Topics: Animals; Dog Diseases; Dogs; Double-Blind Method; Gastrointestinal Hemorrhage; Glucocorticoids; Omeprazole; Prednisone; Probiotics | 2023 |
30 other study(ies) available for omeprazole and prednisone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
[Bullous pemphigoid secondary corticoresistant. Inhibitory role of omeprazole on corticosteroid metabolism?].
Topics: Adult; Drug Interactions; Drug Resistance; Female; Humans; Microsomes, Liver; Omeprazole; Pemphigoid, Bullous; Peptic Ulcer; Prednisone; Recurrence | 1991 |
[Possibility of prednisone-omeprazole interference in bullous pemphigoid].
Topics: Adult; Drug Interactions; Female; Humans; Omeprazole; Pemphigoid, Bullous; Prednisone; Recurrence; Ulcer | 1990 |
Facial swelling and eosinophilia in a 44-year-old woman.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Angioedema; Cefuroxime; Cetirizine; Diagnosis, Differential; Drug Hypersensitivity; Edema; Eosinophilia; Face; Fatigue; Female; Humans; Hypereosinophilic Syndrome; Indoles; Lansoprazole; Methylprednisolone; Methylprednisolone Acetate; Omeprazole; Penicillins; Phenylcarbamates; Prednisone; Ranitidine; Recurrence; Sulfonamides; Syndrome; Terfenadine; Tosyl Compounds | 2002 |
[Heartburn without esophagitis. Symptoms more important than the finding?].
Topics: Androstadienes; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Aspirin; Barrett Esophagus; Child; Cross-Over Studies; Cyclooxygenase Inhibitors; Deglutition Disorders; Diagnosis, Differential; Double-Blind Method; Dyspepsia; Endoscopy; Eosinophilia; Esophagitis; Esophagitis, Peptic; Family Practice; Fluticasone; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Middle Aged; Omeprazole; Prednisone; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Surveys and Questionnaires; Time Factors | 2003 |
Acute interstitial nephritis due to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Benzimidazoles; Biopsy; Ciprofloxacin; Creatinine; Female; Gastroesophageal Reflux; Humans; Kidney; Nephritis, Interstitial; Oliguria; Omeprazole; Pantoprazole; Prednisone; Proton Pump Inhibitors; Proton Pumps; Sulfoxides; Time Factors | 2004 |
Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biopsy; Child; Cimetidine; Diagnosis, Differential; Enzyme Inhibitors; Eosinophilia; Esophagitis; Esophagoscopy; Esophagus; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Omeprazole; Prednisone | 2004 |
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Azathioprine; Duodenal Ulcer; Eosinophilia; Female; Gastritis; Gastroenteritis; Gastroscopy; Glucocorticoids; Humans; Immunosuppressive Agents; Lansoprazole; Middle Aged; Omeprazole; Prednisone; Proton Pump Inhibitors; Stomach Ulcer; Treatment Failure | 2004 |
Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Mitoxantrone; Neoplasm Staging; Omeprazole; Pantoprazole; Patient Compliance; Prednisone; Proton Pump Inhibitors; Rituximab; Stomach Neoplasms; Sulfoxides; Treatment Outcome; Vincristine | 2005 |
Collagenous gastritis: a rare cause of abdominal pain and iron-deficiency anemia.
Topics: Abdominal Pain; Anemia, Iron-Deficiency; Anti-Ulcer Agents; Biopsy; Child; Collagen; Collagen Diseases; Duodenitis; Endoscopy; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Glucocorticoids; Helicobacter Infections; Helicobacter pylori; Humans; Nausea; Omeprazole; Prednisone; Rare Diseases; Vomiting; Weight Loss | 2007 |
[Esophageal Crohn's disease].
Topics: Adrenal Cortex Hormones; Adult; Algorithms; Anti-Ulcer Agents; Crohn Disease; Cyclosporine; Endoscopy, Digestive System; Esophagitis; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Middle Aged; Omeprazole; Prednisone; Tumor Necrosis Factor-alpha | 2008 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
Tuberculosis in a patient on temozolomide: a case report.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antibiotics, Antitubercular; Anticholesteremic Agents; Anticonvulsants; Antineoplastic Agents, Alkylating; Atorvastatin; Brain Neoplasms; Combined Modality Therapy; Cyclosporine; Dacarbazine; Dexamethasone; Female; Fluoxetine; Glioblastoma; Heptanoic Acids; Humans; Immunosuppressive Agents; Isoniazid; Middle Aged; Omeprazole; Phenobarbital; Prednisone; Pyrazinamide; Pyrroles; Radiotherapy; Red-Cell Aplasia, Pure; Rifampin; Temozolomide; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary | 2009 |
[Atypical manifestations of acute posterior placoid pigment epitheliopathy].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Cysts; Drug Therapy, Combination; Fluorescein Angiography; Fovea Centralis; Humans; Male; Omeprazole; Pigment Epithelium of Eye; Prednisone; Respiratory Tract Infections; Retinal Detachment; Retinal Diseases; Retinal Hemorrhage; Tomography, Optical Coherence; Vision Disorders | 2010 |
A case of subglottic and diffuse tracheal stenoses appearing responsive to macrolide therapy.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Child; Dyspnea; Enzyme Inhibitors; Humans; Laryngostenosis; Male; Omeprazole; Prednisone; Respiratory Sounds; Tracheal Stenosis | 2012 |
Statin-associated polymyositis following omeprazole treatment.
Topics: Anticholesteremic Agents; Atorvastatin; Drug Interactions; Esophagitis; Gemfibrozil; Heptanoic Acids; Humans; Male; Methotrexate; Middle Aged; Myocardial Infarction; Omeprazole; Polymyositis; Prednisone; Proton Pump Inhibitors; Pyrroles; Treatment Outcome; Withholding Treatment | 2013 |
Granulomatous tubulointerstitial nephritis secondary to omeprazole.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Middle Aged; Nephritis, Interstitial; Omeprazole; Prednisone; Proton Pump Inhibitors; Ranitidine; Renal Dialysis | 2014 |
Reversible vascular calcifications associated with hypervitaminosis D.
Topics: Biomarkers; Calcium; Cholecalciferol; Diuretics; Fluid Therapy; Furosemide; Glucocorticoids; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Nutrition Disorders; Omeprazole; Prednisone; Proton Pump Inhibitors; Remission Induction; Sodium Chloride; Time Factors; Treatment Outcome; Up-Regulation; Vascular Calcification; Vitamin D | 2016 |
Quiz Page March 2016: A 60-Year-Old Man With Fever, Night Sweats, and Acute Kidney Injury.
Topics: Biopsy; Creatinine; Diagnosis, Differential; Gastroesophageal Reflux; Glucocorticoids; Humans; Kidney; Kidney Tubular Necrosis, Acute; Male; Microscopy, Polarization; Middle Aged; Omeprazole; Prednisone; Proton Pump Inhibitors; Treatment Outcome; Withholding Treatment | 2016 |